Le produit a bien été ajouté au panier.

discount label
H-LDEETGEFL-NH2
Vue en 3D

Biosynth logo

H-LDEETGEFL-NH2

Ref. 3D-PP48459

Taille indéfinieÀ demander
Livraison estimée en/au États-Unis, le mardi 3 décembre 2024

Informations sur le produit

Nom :
H-LDEETGEFL-NH2
Description :

Peptide H-LDEETGEFL-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LDEETGEFL-NH2 include the following: Design and synthesis of disulfide-rich peptides with orthogonal disulfide pairing motifs Z Huang, Y Wu, H Dong, Y Zhao - The Journal of Organic , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.joc.0c01600 Kinetic analyses of Keap1-Nrf2 interaction and determination of the minimal Nrf2 peptide sequence required for Keap1 binding using surface plasmon resonance Y Chen, D Inoyama, ANT Kong - Chemical biology & , 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1747-0285.2011.01240.x Exploring the binding of rationally engineered tandem-repeat proteins to E3 ubiquitin ligase Keap1 SK Madden , LS Itzhaki - Protein Engineering, Design and , 2021 - academic.oup.comhttps://academic.oup.com/peds/article-abstract/doi/10.1093/protein/gzab027/6457287 Small molecule modulators of K eap1-N rf2-ARE pathway as potential preventive and therapeutic agents S Magesh, Y Chen, L Hu - Medicinal research reviews, 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/med.21257 Activators and inhibitors of NRF2: a review of their potential for clinical development N Robledinos-Anton - Oxidative medicine , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2019/9372182 The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update MC Lu, JA Ji, ZY Jiang, QD You - Medicinal research reviews, 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/med.21396 Interaction energetics and druggability of the protein-protein interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 M Zhong , A Lynch, SN Muellers, S Jehle, L Luo - Biochemistry, 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.biochem.9b00943 Prediction of binding energy of Keap1 interaction motifs in the Nrf2 antioxidant pathway and design of potential high-affinity peptides M Karttunen , WY Choy , EA Cino - The Journal of Physical , 2018 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jpcb.8b03295 Inhibiting the Keap1/Nrf2 Protein-Protein Interaction with Protein-Like Polymers KP Carrow, HL Hamilton, MP Hopps, Y Li - Advanced , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adma.202311467 Virtual screening expands the non-natural amino acid palette for peptide optimization KN Amarasinghe , L De Maria, C Tyrchan - Journal of Chemical , 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jcim.2c00193 Combined peptide and small-molecule approach toward nonacidic THIQ inhibitors of the KEAP1/NRF2 interaction JM Ontoria, I Biancofiore, P Fezzardi - ACS Medicinal , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsmedchemlett.9b00594 Peptide Macrocycles Developed from Precisely Regulated Multiple Cyclization of Unprotected Peptides J Wang, M Zha, Q Fei, W Liu, Y Zhao - Chemistry-A European , 2017 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/chem.201703139 Novel protein-protein interaction inhibitor of Nrf2-Keap1 discovered by structure-based virtual screening HP Sun , ZY Jiang, MY Zhang, MC Lu, TT Yang - , 2014 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2014/md/c3md00240c A Case Study on the Keap1 Interaction with Peptide Sequence Epitopes Selected by the Peptidomic mRNA Display H Hirose , T Hideshima, T Katoh , H Suga - ChemBioChem, 2019 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/cbic.201900039 Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction G Wells - Biochemical Society Transactions, 2015 - portlandpress.comhttps://portlandpress.com/biochemsoctrans/article-abstract/43/4/674/88607 Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents DA Abed, M Goldstein, H Albanyan, H Jin - Acta Pharmaceutica Sinica , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2211383515000829 Strategies for converting turn-motif and cyclic peptides to small molecules for targeting protein-protein interactions D Hayward, AM Beekman - RSC Chemical Biology, 2024 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2024/cb/d3cb00222e Structural Basis for the Nrf2 interaction with the Keap1 repressor B Padmanabhan, KI Tong, Y Nakamura, A Kobayashi - researchgate.nethttps://www.researchgate.net/profile/Akira-Kobayashi-3/publication/266354656_Structural_Basis_for_the_Nrf2_interaction_with_the_Keap1_repressor/links/55b3215308aed621ddfe17f0/Structural-Basis-for-the-Nrf2-interaction-with-the-Keap1-repressor.pdf

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP48459 H-LDEETGEFL-NH2

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".